Download Citation on ResearchGate | Advances in the diagnosis, pathogenesis and treatment of CIDP | Chronic inflammatory demyelinating. This Review highlights the recent advances in diagnosing CIDP, provides an update on the immunopathology including new target antigens. CIDP is an acquired immune-mediated inflammatory disorder sometimes Advances in the diagnosis, pathogenesis and treatment of CIDP.
|Country:||Papua New Guinea|
|Published (Last):||25 October 2010|
|PDF File Size:||15.65 Mb|
|ePub File Size:||20.45 Mb|
|Price:||Free* [*Free Regsitration Required]|
Current diagnosis of CIDP: From This Paper Figures, tables, and topics from this paper.
Advances in the diagnosis, pathogenesis and treatment of CIDP
Showing of references. Citations Publications citing this paper.
Review of the evolution of electrodiagnostic criteria for chronic inflammatory demyelinating polyradicoloneuropathy. Commonly used immunosuppressive drugs offer minimal benefit, necessitating the development of new therapies for treatment-refractory patients.
Subcutaneous IgG for chronic inflammatory demyelinating polyneuropathy Marinos C. Bertsias Current opinion in rheumatology MRI assessment including apparent diffusion coefficient.
References Publications referenced by this paper. An open label clinical trial of complement inhibition in multifocal motor neuropathy. An update on the management of chronic inflammatory demyelinating polyneuropathy.
Brannagan Journal of the peripheral nervous system: Despite clinical challenges in diagnosis-owing in part to the existence of disease variants, and different views on how many electrophysiological abnormalities are needed to document demyelination-consensus criteria seem to have been reached for research or clinical practice.
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Search for additional papers on this topic. BoumpasGeorge K. This paper has been referenced on Twitter 1 time over the past 90 days.
Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: Skip to search form Skip to main content. Evidence from Human and Animal Studies: John David PollardPatricia J.
Chronic inflammatory demyelinating polyneuropathy CIDP is the most common chronic autoimmune neuropathy. Pathogenesis and treatment of CNS lupus. Dalakas The Lancet Neurology Antonis FanouriakisDimitrios T.
Armati Journal of the advancfs nervous system: Despite clinical challenges in diagnosis—owing in part to the existence of disease variants, and different views on patyogenesis many electrophysiological abnormalities are needed to document demyelination—consensus criteria seem to have been reached for research or clinical practice.
New biomarkers and scoring systems represent emerging tools with the potential to predict ov responses and identify patients with active disease for enrollment into clinical trials. Showing of 60 extracted citations. Topics Discussed in This Paper.
Maintenance therapy with IVIg can induce sustained remission, increase quality of life and prevent further axonal loss, but caution is needed to avoid overtreatment. Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Immunoglobulins, Intravenous Demyelinating peripheral neuropathy Polyneuropathy. Diagnostic insights into chronic-inflammatory demyelinating polyneuropathies.